Nausea management is the main practical challenge
It is NOT approved for human injection, ingestion, therapeutic application, or any other form of human exposure
Adotvi O, Vernerey D, Jacoulet P, Meurisse A, Laheurte C, Almotlak H, Jacquin M, Kaulek V, Boullerot L et al (2023) Safety, immunogenicity, and 1-year efficacy of universal cancer peptide-based vaccine in patients with refractory advanced non-small-cell lung cancer: a phase Ib/phase IIa de-escalation study
3 Geographic variations in antileishmanial drug resistance Treatment options for leishmaniasis vary significantly by region due to differences in dominant Leishmania species and emerging drug resistance patterns (Ponte-Sucre et al., 2017)
NHLBI Exome Sequencing Project (ESP)
van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al